Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD (Q44915714)

7 December 2017

title

Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD (English)

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

chronic obstructive pulmonary disease

1 December 2024

main subject

1 reference

based on heuristic

inferred from title

budesonide/formoterol

1 reference

Jennifer McElhattan

4

1 reference

7 December 2017

Bartolome R. Celli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21531124

1 December 2024

Donald P. Tashkin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21531124

1 December 2024

Stephen I. Rennard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21531124

1 December 2024

Ubaldo J. Martin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21531124

1 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21531124

1 December 2024

publication date

30 April 2011

1 reference

full work available at URL

7 December 2017

http://www.resmedjournal.com/article/S0954611111000692/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21531124

https://api.elsevier.com/content/article/PII:S0954611111000692?httpAccept=text/xml

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

https://api.elsevier.com/content/article/PII:S0954611111000692?httpAccept=text/plain

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

1 December 2024

1 reference

7 December 2017

volume

105

1 reference

7 December 2017

issue

8

1 reference

7 December 2017

page(s)

1176-1188

1 reference

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

7 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses

1 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Efficacy of salmeterol xinafoate in the treatment of COPD

1 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Bronchodilator responsiveness in patients with COPD.

1 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

1 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

1 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD.

1 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction

1 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial

1 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial

1 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society

1 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Discriminating asthma and COPD based on bronchodilator data: an improvement of the methods

1 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Interpretative strategies for lung function tests

1 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

1 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility

1 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation

1 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

1 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

1 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Interactions between corticosteroids and beta agonists

1 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility

1 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.

1 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest

1 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.

1 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease

1 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey

1 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.02.020

1 December 2024

Identifiers

1 reference

7 December 2017

1 reference